The Chemotherapy Board provides guidance, oversight and support for the continuing development of chemotherapy services in the UK.
The UK Chemotherapy Board was established in 2013 by The Royal College of Radiologists (RCR), the Royal College of Physicians (RCP), the Association of Cancer Physicians (ACP), the Royal College of Pathologists (RCPath), the British Oncology Pharmacy Association (BOPA) and the UK Oncology Nursing Society (UKONS). The Board has representation from across the four UK nations and from other organisations closely involved in SACT services.
The UK SACT (Systemic Anti-Cancer Therapy) Board provides guidance, oversight and support for the continuing development of SACT services in the UK.
Netty Cracknell
BOPA Representative
Netty Cracknell
Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK and is currently Lead Cancer Pharmacist for Ramsay Health Care UK. She is President -Elect at The International Society of Oncology Pharmacy Practitioners (ISOPP), website manager for the British Oncology Pharmacy Association (BOPA) and a member of the UK SACT Board. Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023.
Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media. Netty also has a keen interest in education and training and uses her strengths of IT and enthusiasm to support all pharmacy staff in all sectors and countries to improve access to education and training globally.
Joseph Williams
BOPA Representative
Joseph Williams
Joseph is a Specialist Cancer and Homecare Pharmacist at The Christie NHS Foundation Trust and has previously been a member of the Cancer team at Royal Manchester Children’s Hospital (RMCH) and University College London Hospitals NHS Foundation Trust (UCLH) with a specialist interest in colorectal cancer and antimicrobial stewardship. He is also an independent prescriber within the colorectal cancer speciality.
Joseph is also an Honorary Clinical Lecturer in the Division of Pharmacy & Optometry at the University of Manchester (UoM) where he teaches a variety of topics including Cancer for Undergraduates and Postgraduates. His background has vastly been in clinical practice and his patient facing role within the MDT has allowed him to initiate and progress applied health research projects in his area of practice to benefit patient care. He has also been fortunate to have had many opportunities to work with students in Higher Education Institutions around the country and has always been passionate about supporting students and teaching.
Joseph is passionate about promoting excellence in pharmaceutical care of patients with cancer through education, research, and innovation.
Joseph is Chair of BOPA and is also a member of the BOPA Digital, E&T, EDI and Research Sub-committees. He has previously been Secretary and Vice Chair of BOPA.
Specialist Advisory Groups
There are several specialist interest groups with BOPA. The groups and BOPA work together jointly to promote excellence in the pharmaceutical care of patients with cancer through education, communication, research or innovation.
There are several subcommittees & working groups that report directly to the Executive Committee each month. These subcommittees & working groups support the executive committee and keep the organisation at the forefront of care.
The Executive Committee work on behalf of the BOPA members to prioritise and co-ordinate the many activities and workstreams required to achieve our goals
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.
